# Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial

> **NCT00414726** · PHASE2 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 85 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** NBO (Normobaric Oxygen)
- **DRUG:** Room Air

## Key facts

- **NCT ID:** NCT00414726
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 85 (ACTUAL)
- **Why stopped:** Imbalance in deaths favoring control arm; deaths not attributed to treatment by the blinded external medical monitor.
- **Last updated:** 2017-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414726, "Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00414726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*